Not available
Quote | Axsome Therapeutics Inc. (NASDAQ:AXSM)
Last: | $86.53 |
---|---|
Change Percent: | -0.41% |
Open: | $86.33 |
Close: | $86.53 |
High: | $86.93 |
Low: | $85.05 |
Volume: | 258,879 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Axsome Therapeutics Inc. (NASDAQ:AXSM)
PALM BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The fibromyalgia treatment market has witnessed positive growth trends over the past few years. There is higher disease awareness due to growth in diagnosis rates and growing awareness and concern for this se...
2024-07-15 07:15:00 ET Any stock can have an impressive run, especially when broader equities are experiencing a bull market. Significantly fewer stocks can perform well through good and not-so-good times and deliver excellent returns over long periods. These are precisely the sort of corpo...
Message Board Posts | Axsome Therapeutics Inc. (NASDAQ:AXSM)
Subject | By | Source | When |
---|---|---|---|
$AXSM Price now last trade up | Frankestin | investorshub | 06/27/2023 11:05:09 PM |
$AXSM best news of the day | MiamiGent | investorshub | 06/26/2023 5:43:47 AM |
New mid term topic $100.00 by or before | georgejjl | investorshub | 06/23/2023 4:29:46 PM |
$AXSM what do you make of this data? | georgejjl | investorshub | 06/23/2023 3:51:48 PM |
Their target has been reached. Now what? | rosemountbomber | investorshub | 06/23/2023 12:11:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Axsome Therapeutics Inc. Company Name:
AXSM Stock Symbol:
NASDAQ Market:
Axsome Therapeutics Inc. Website:
PALM BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The fibromyalgia treatment market has witnessed positive growth trends over the past few years. There is higher disease awareness due to growth in diagnosis rates and growing awareness and concern for this se...
2024-07-15 07:15:00 ET Any stock can have an impressive run, especially when broader equities are experiencing a bull market. Significantly fewer stocks can perform well through good and not-so-good times and deliver excellent returns over long periods. These are precisely the sort of corpo...
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it will report its financial results for the second quarter of ...